Vollenweider, F. X., Vontobel, P., Hell, D., & Leenders, K. L.. (1999). 5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in Man – A PET study with [11C]raclopride. Neuropsychopharmacology

Plain numerical DOI: 10.1016/S0893-133X(98)00108-0
DOI URL
directSciHub download

Carter, O. L., Burr, D. C., Pettigrew, J. D., Wallis, G. M., Hasler, F., & Vollenweider, F. X.. (2005). Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors. Journal of Cognitive Neuroscience

Plain numerical DOI: 10.1162/089892905774597191
DOI URL
directSciHub download

Kometer, M., Schmidt, A., Bachmann, R., Studerus, E., Seifritz, E., & Vollenweider, F. X.. (2012). Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors. Biological Psychiatry

Plain numerical DOI: 10.1016/j.biopsych.2012.04.005
DOI URL
directSciHub download

Schmidt, A., Kometer, M., Bachmann, R., Seifritz, E., & Vollenweider, F.. (2013). The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions. Psychopharmacology

Plain numerical DOI: 10.1007/s00213-012-2811-0
DOI URL
directSciHub download

González-Maeso, J., Weisstaub, N. V., Zhou, M., Chan, P., Ivic, L., Ang, R., … Gingrich, J. A.. (2007). Hallucinogens Recruit Specific Cortical 5-HT 2A Receptor-Mediated Signaling Pathways to Affect Behavior. Neuron

Plain numerical DOI: 10.1016/j.neuron.2007.01.008
DOI URL
directSciHub download

Vollenweider, F. X., Csomor, P. A., Knappe, B., Geyer, M. A., & Quednow, B. B.. (2007). The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval. Neuropsychopharmacology

Plain numerical DOI: 10.1038/sj.npp.1301324
DOI URL
directSciHub download

Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P., & Griffiths, R. R.. (2014). Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. Journal of Psychopharmacology

Plain numerical DOI: 10.1177/0269881114548296
DOI URL
directSciHub download

Umbricht, D., Vollenweider, F. X., Schmid, L., Grübel, C., Skrabo, A., Huber, T., & Koller, R.. (2003). Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: Implications for the neuropharmacology of cognitive deficitsin schizophrenia. Neuropsychopharmacology

Plain numerical DOI: 10.1038/sj.npp.1300005
DOI URL
directSciHub download

Wittmann, M., Carter, O., Hasler, F., Cahn, B. R., Grimberg, U., Spring, P., … Vollenweider, F. X.. (2007). Effects of psilocybin on time perception and temporal control of behaviour in humans. Journal of Psychopharmacology

Plain numerical DOI: 10.1177/0269881106065859
DOI URL
directSciHub download

Kometer, M., Schmidt, A., Jancke, L., & Vollenweider, F. X.. (2013). Activation of Serotonin 2A Receptors Underlies the Psilocybin-Induced Effects on Oscillations, N170 Visual-Evoked Potentials, and Visual Hallucinations. Journal of Neuroscience

Plain numerical DOI: 10.1523/jneurosci.3007-12.2013
DOI URL
directSciHub download